33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comprehensive breast cancer (BC) risk assessment for CHEK2 carriers incorporating a polygenic risk score (PRS) and the Tyrer-Cuzick (TC) model
    Meeting Abstract

    Gallagher, S.; Hughes, E.; Kurian, A. W.; Domchek, S. M.; Garber, J. E.; Probst, B.; Morris, B.; Tshiaba, P.; Rosenthal, E. T.; Roa, B.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Preliminary results of the organ preservation of rectal adenocarcinoma (OPRA) trial
    Meeting Abstract

    Garcia-Aguilar, J.; Patil, S.; Kim, J. K.; Yuval, J. B.; Thompson, H.; Verheij, F.; Lee, M.; Saltz, L. B.; on behalf of the OPRA Consortium
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Incidence of brain metastases in patients receiving neoadjuvant chemotherapy (NAC) with trastuzumab and pertuzumab (HP) in HER2-positive early breast cancer (BC)
    Meeting Abstract

    Ferraro, E.; Barrio, A. V.; Patil, S.; Robson, M. E.; Dang, C. T.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Evaluation of predictive biomarkers for nivolumab in patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC) from the CheckMate-025 (CM-025) trial
    Meeting Abstract

    Ficial, M.; Jegede, O.; Sant'Angelo, M.; Moreno, S.; Braun, D. A.; Wind-Rotolo, M.; Pignon, J. C.; Catalano, P. J.; Sun, M. X. N.; Van Allen, E. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Nivolumab (NIVO) plus ipilimumab (IPI) with two cycles of chemotherapy (chemo) in first-line metastatic non-small cell lung cancer (NSCLC): CheckMate 568 Part 2
    Meeting Abstract

    Gainor, J. F.; Schneider, J. G.; Gutierrez, M.; Orcutt, J. M.; Finley, G. G.; Otterson, G. A.; Rybkin, I. I.; Reddy, P. S.; Horn, L.; Brahmer, J. R.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Prospective agnostic germline testing in pediatric cancer patients
    Meeting Abstract

    Fiala, E.; Kennedy, J.; Kemel, Y.; Mauguen, A.; Mandelker, D.; Zehir, A.; Birsoy, O.; Bouvier, N.; Maio, A.; Latham, A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • CodeBreak 100: Activity of AMG 510, a novel small molecule inhibitor of KRAS(G12C), in patients with advanced colorectal cancer
    Meeting Abstract

    Fakih, M.; Desai, J.; Kuboki, Y.; Strickler, J. H.; Price, T. J.; Durm, G. A.; Falchook, G. S.; Denlinger, C. S.; Krauss, J. C.; Shapiro, G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase I/Ib study of lenvatinib and cetuximab in patients with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Dunn, L.; Ho, A. L.; Eng, J.; Michel, L. S.; Fetten, J. V.; Warner, E.; Kriplani, A.; Zhi, W. I.; Ng, K. K.; Haque, S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase II, multicenter study of encorafenib/binimetinib followed by a rational triple-combination after progression in patients with advanced BRAF V600-mutated melanoma (LOGIC2)
    Meeting Abstract

    Dummer, R.; Sandhu, S. K.; Miller, W. H.; Butler, M. O.; Blank, C. U.; Muñoz-Couselo, E.; Burris, H. A. 3rd; Postow, M. A.; Chmielowski, B.; Middleton, M. R.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Uptake of oophorectomy in women with findings on multigene panel testing: Results from the Prospective Registry of Multiplex Testing (PROMPT)
    Meeting Abstract

    Domchek, S. M.; Brower, J.; Symecko, H.; Marcell, V.; Walsh, M. F.; Hamilton, J. G.; Couch, F.; Offit, K.; Garber, J. E.; Robson, M. E.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save